Levels of matrix metalloproteinase-2 and metalloproteinase-9 in the cerebrospinal fluid of dogs with visceral leishmaniasis

被引:20
|
作者
Marangoni, N. R. [1 ]
Melo, G. D. [1 ]
Moraes, O. C. [1 ]
Souza, M. S. [1 ]
Perri, S. H. V. [2 ]
Machado, G. F. [1 ]
机构
[1] UNESP Univ Estadual Paulista, Dept Anim Clin Surg & Reprod, Coll Vet Med, Sao Paulo, Brazil
[2] UNESP Univ Estadual Paulista, Dept Anim Prod & Hlth, Coll Vet Med, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
central nervous system; inflammation; Leishmania chagasi; MMP-2; MMP-9; zymography; ENTRY; SERUM;
D O I
10.1111/j.1365-3024.2011.01285.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Inflammation causes increases in the level of matrix metalloproteinases (MMPs), which, in central nervous system (CNS), are associated with neuroinflammation and disruption of blood-brain barrier. Analysis of cerebrospinal fluid (CSF) is pivotal for detecting diseases in CNS and, although a specific diagnosis may not be achieved, this analysis is helpful to confirm the diagnosis or to rule out relevant differential diagnoses. This study examined the levels of MMP-2 and MMP-9 in the CSF of dogs using gelatin zymography to verify possible alterations in these enzymes during natural systemic infection with Leishmania chagasi. Latent and active forms of MMP-2 were detected in some dogs of both groups, with high levels in the control group. In contrast, latent and active forms of MMP-9 were detected only in some animals with leishmaniasis. These results clearly demonstrate that MMP-9 is elevated in CSF of dogs with visceral leishmaniasis (VL). Although these results are preliminary, they suggest that MMP-9 might play a role in disruption of blood-brain barrier and/or blood-CSF barrier. While the presence of MMPs in CSF is not a condition exclusive to VL, their presence and persistence in CSF supports the hypothesis of an inflammatory state within CNS of dogs with VL.
引用
收藏
页码:330 / 334
页数:5
相关论文
共 50 条
  • [21] Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Expressions Correlate with the Recurrence of Intracranial Meningiomas
    Masaki Okada
    Keisuke Miyake
    Yoshihito Matsumoto
    Nobuyuki Kawai
    Katsuzo Kunishio
    Seigo Nagao
    Journal of Neuro-Oncology, 2004, 66 : 29 - 37
  • [22] Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis
    Ichiyama, Takashi
    Matsushige, Takeshi
    Siba, Peter
    Suarkia, Dagwin
    Takasu, Toshiaki
    Miki, Kenji
    Furukawa, Susumu
    JOURNAL OF INFECTION, 2008, 56 (05) : 376 - 380
  • [23] Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2
    Zhou Shao-fei
    Hu San-yuan
    Ma Lei
    Miao Lei
    Mao Wei-zheng
    CHINESE MEDICAL JOURNAL, 2013, 126 (10) : 1925 - 1929
  • [24] Clinical Significance of Plasma Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Levels to Assess the Cardiovascular Risk in Hemodialysis Patients
    Lee, Yu Ho
    Lee, So-young
    Jeong, Hyeyun
    Kim, Yang Gyun
    Moon, Ju Young
    Lee, Sangho
    Kim, Jin Sug
    Jeong, Kyung Hwan
    Ahn, Shin-Young
    Lee, Dong-Young
    Hwang, Hyeon Seok
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 299 - 299
  • [25] Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
    Wang, Ling-Feng
    Chien, Chen-Yu
    Chiang, Feng-Yu
    Chai, Chee-Yin
    Tai, Chih-Feng
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (01): : 26 - 31
  • [26] Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
    Trentini, Alessandro
    Castellazzi, Massimiliano
    Cervellati, Carlo
    Manfrinato, Maria Cristina
    Tamborino, Carmine
    Hanau, Stefania
    Volta, Carlo Alberto
    Baldi, Eleonora
    Kostic, Vladimir
    Drulovic, Jelena
    Granieri, Enrico
    Dallocchio, Franco
    Bellini, Tiziana
    Dujmovic, Irena
    Fainardi, Enrico
    DISEASE MARKERS, 2016, 2016
  • [27] In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese
    Chebassier, N
    El Houssein, O
    Viegas, I
    Dréno, B
    EXPERIMENTAL DERMATOLOGY, 2004, 13 (08) : 484 - 490
  • [28] Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection
    Campbell, LG
    Ramachandran, S
    Liu, W
    Shipley, JM
    Itohara, S
    Rogers, JG
    Moazami, N
    Senior, RM
    Jaramillo, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 517 - 528
  • [29] Whole Blood Assay for Elastase, Chymotrypsin, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Activity
    Lefkowitz, Roy B.
    Schmid-Schoenbein, Geert W.
    Heller, Michael J.
    ANALYTICAL CHEMISTRY, 2010, 82 (19) : 8251 - 8258
  • [30] Difference in expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in patients with persistent ovarian cysts
    Raspollini, MR
    Castiglione, F
    Degl'Innocenti, DR
    Garbini, F
    Coccia, ME
    Taddei, GL
    FERTILITY AND STERILITY, 2005, 84 (04) : 1049 - 1052